| Literature DB >> 24095935 |
Michelle Marshall1, Elaine Nicholls1, Wing-Yee Kwok2, George Peat1, Margreet Kloppenburg2, Danielle van der Windt1, Helen Myers1, Krysia Dziedzic1.
Abstract
OBJECTIVES: To determine whether erosive osteoarthritis shares the same pattern of joint involvement and risk profile as increasing grades of non-erosive hand osteoarthritis.Entities:
Keywords: Epidemiology; Hand Osteoarthritis; Osteoarthritis
Mesh:
Year: 2013 PMID: 24095935 PMCID: PMC4283656 DOI: 10.1136/annrheumdis-2013-203948
Source DB: PubMed Journal: Ann Rheum Dis ISSN: 0003-4967 Impact factor: 19.103
The rank order and frequency of joint involvement for increasing grades of radiographic osteoarthritis and erosive osteoarthritis
| Right hand | Left hand | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Rank | K&L≥2 | K&L≥3 | K&L=4 | Erosive osteoarthritis | Rank | K&L≥2 | K&L≥3 | K&L=4 | Erosive osteoarthritis |
| 1 | DIP2 (30.3%) | DIP2 (15.1%) | DIP2 (6.3%) | DIP2 (3.6%) | 1 | DIP2 (21.9%) | DIP2 (10.0%) | DIP2 (4.1%) | DIP2 (3.2%) |
| 2 | DIP5 (27.2%) | DIP3 (9.1%) | DIP3 (3.6%) | DIP3 (2.5%) | 2 | DIP5 (19.9%) | DIP5 (8.2%) | DIP3 (3.7%) | DIP3 (1.9%) |
| 3 | DIP3 (22.7%) | DIP5 (8.2%) | DIP5 (3.3%) | DIP5 (2.0%) | 3 | DIP3 (15.1%) | DIP3 (7.5%) | DIP5 (3.5%) | DIP5 (1.5%) |
| 4 | PIP5 (12.0%) | DIP4 (4.9%) | DIP4 (1.6%) | DIP4 & PIP3 (0.7%) | 4 | PIP2 (9.7%) | DIP4 (4.0%) | DIP4 (2.1%) | DIP4 (1.0%) |
| 5 | PIP2 (11.8%) | PIP3 (3.2%) | PIP3 (1.4%) | 5 | PIP5 (9.0%) | PIP4 (2.5%) | PIP3 (1.1%) | PIP4 (0.7%) | |
| 6 | PIP3 (11.3%) | PIP4 (2.2%) | PIP4 (1.0%) | PIP4 (0.6%) | 6 | PIP3 (8.7%) | PIP3 (2.0%) | PIP4 (0.8%) | PIP5 & PIP3 (0.3%) |
| 7 | DIP4 (10.8%) | PIP2 (2.0%) | PIP2 & PIP5 (0.5%) | PIP5 (0.3%) | 7 | DIP4 (8.3%) | PIP5 & PIP2 (1.9%) | PIP5 (0.5%) | |
| 8 | PIP4 (6.8%) | PIP5 (1.7%) | PIP2 (0.1%) | 8 | PIP4 (6.3%) | PIP2 (0.4%) | PIP2 (0.1%) | ||
| Spearman rank correlations | 0.611, p=0.108 | 0.970, p<0.001 | 0.988, p<0.001 | Reference | Spearman rank correlations | 0.539, p=0.168 | 0.958, p<0.001 | 0.958, p<0.001 | Reference |
Percentages represent the proportion of joints affected with increasing grades of non-erosive radiographic osteoarthritis and erosive osteoarthritis out of the total number of joints examined.
DIP, distal interphalangeal joint; K&L, Kellgren and Lawrence; PIP, proximal interphalangeal joint.
Patterns of joint involvement by symmetry, row and ray for increasing grades of radiographic osteoarthritis and erosive osteoarthritis
| Groups of Joints | K&L≥2 | K&L≥3 | K&L=4 | Erosive osteoarthritis | ||||
|---|---|---|---|---|---|---|---|---|
| aOR | (95% CI) | aOR | (95% CI) | aOR | (95% CI) | aOR | (95% CI) | |
| Same joint, opposite hand | 3.8 | (3.1 to 4.5) | 6.0 | (4.2 to 8.5) | 6.0 | (3.4 to 10.5) | 6.5 | (3.0 to 14.1) |
| Same row, same hand | 3.2 | (2.7 to 3.8) | 3.1 | (2.1 to 4.6) | 4.2 | (2.3 to 7.8) | 2.0 | (0.8 to 5.0) |
| Same ray, same hand | 0.9 | (0.7 to 1.2) | 0.5 | (0.3 to 0.9) | 0.3 | (0.1 to 0.8) | 0.3 | (0.03 to 2.5) |
aOR, adjusted OR for age, gender, hand joint, hand side and number of affected interphalangeal joints; K&L, Kellgren and Lawrence.
Demographic and radiographic characteristics of individuals with erosive osteoarthritis compared to the reference groups with increasing grades of non-erosive radiographic hand osteoarthritis
| K&L≥3 | K&L=4 | Erosive osteoarthritis | |
|---|---|---|---|
| Number | n=193 | n=68 | n=80 |
| Age range, years | 52–91 | 55–85 | 51–87 |
| Mean age, years (SD) | 68.9 (8.1) | 69.1 (7.5) | 69.2 (7.8) |
| Female gender | 79.3% | 79.4% | 83.8% |
| Thumb IPJ osteoarthritis* | 63.7% | 69.1% | 68.8% |
| Thumb MCP osteoarthritis* | 14.0% | 16.2% | 23.8% |
| First CMC osteoarthritis* | 71.0% | 66.2% | 76.3% |
| Trapezioscaphoid joint osteoarthritis* | 30.6% | 27.9% | 29.1% |
| MCP osteoarthritis† | 30.6% | 35.3% | 32.5% |
| Symptomatic radiographic knee osteoarthritis‡ | 68.5% | 59.7% | 55.4% |
| Manual occupation | 56.3% | 56.5% | 48.6% |
| Attended higher education | 14.9% | 16.7% | 21.5% |
| Family history of arthritis | 68.4% | 63.2% | 71.2% |
| Previous hand injury | 25.4% | 24.6% | 32.9% |
| Excessive hand use at work or in pastimes | 77.6% | 76.2% | 83.8% |
| BMI>30 kg/m2 | 34.4% | 35.3% | 37.5% |
| Type 2 diabetes or impaired fasting glucose | 9.3% | 10.3% | 6.2% |
| Hypertension | 37.8% | 29.4% | 43.8% |
| Dyslipidaemia | 6.2% | 8.8% | 21.2% |
| Prescribed a lipid-regulating drug | 17.1% | 16.2% | 20.0% |
| Metabolic syndrome§ | 4.1% | 2.9% | 11.2% |
BMI, body mass index; CMC, carpometacarpal joint; IPJ, interphalangeal joint; K&L, Kellgren and Lawrence; MCP, metacarpophalangeal joint.
*Radiographic osteoarthritis determined by presence of K&L≥2.
†Radiographic osteoarthritis determined by the presence of K&L≥2 in one or more joints in the joint group.
‡Symptomatic radiographic knee osteoarthritis of tibiofemoral or patella-femoral joints of either knee (K&L≥2 on posterior–anterior or skyline views or posterior or lateral osteophytes Burnett grade≥1 on the lateral views).
§Metabolic syndrome was defined as the presence of three or more of the following: BMI>30 kg/m2, hypertension, dyslipidaemia and type 2 diabetes or impaired fasting glucose.
Risk factors for erosive osteoarthritis compared to reference groups with non-erosive moderate–severe and severe radiographic hand osteoarthritis
| Exposure | Erosive osteoarthritis vs K&L≥3 | Erosive osteoarthritis vs K&L=4 |
|---|---|---|
| aOR (95% CI) | aOR (95% CI) | |
| Female gender | 1.4 (0.7 to 2.7) | 1.3 (0.6 to 3.1) |
| Manual occupation | 0.7 (0.4 to 1.2) | 0.7 (0.4 to 1.4) |
| Attended higher education | 1.6 (0.8 to 3.1) | 1.3 (0.6 to 3.0) |
| Family history of arthritis | 1.2 (0.7 to 2.1) | 1.4 (0.7 to 2.9) |
| Previous hand injury | 1.5 (0.8 to 2.7) | 1.5 (0.7 to 3.3) |
| Excessive hand use at work or in pastimes | 1.6 (0.8 to 3.2) | 1.7 (0.8 to 4.0) |
| BMI>30 kg/m2 | 1.1 (0.6 to 1.9) | 1.1 (0.5 to 2.1) |
| Type 2 diabetes or impaired fasting glucose | 0.6 (0.2 to 1.8) | 0.5 (0.2 to 1.8) |
| Hypertension | 1.2 (0.7 to 2.1) | 1.8 (0.9 to 3.5) |
| Dyslipidaemia | 4.7 (2.1 to 10.6) | 3.4 (1.2 to 9.6) |
| Prescribed a lipid-regulating drug | 1.2 (0.6 to 2.4) | 1.4 (0.6 to 3.2) |
| Metabolic syndrome* | 2.7 (1.0 to 7.1) | 3.2 (0.8 to 13.2) |
aOR, adjusted OR for age and gender; BMI, body mass index; K&L, Kellgren and Lawrence.
*Metabolic syndrome was defined as the presence of three or more of the following: BMI>30 kg/m2, hypertension, dyslipidaemia and type 2 diabetes or impaired fasting glucose.